1. Introduction {#sec1}
===============

Molecular imaging has been applied in the development of precision medicine, where it has improved the accuracy of clinical diagnoses and treatments.^[@ref1]−[@ref4]^ Contrast agents (CAs) composed of nanomaterials and organic materials are extensively applied to molecular imaging.^[@ref5]−[@ref8]^ Using magnetic resonance imaging (MRI) to diagnose liver tumors is a good clinical choice.^[@ref9],[@ref10]^ Compared to routine MRI, current clinical MRI techniques for detecting hepatocellular carcinoma (HCC) achieve higher mean sensitivity and specificity (89.7% and 92%, respectively, compared with 84.9% and 89.7% for routine MRI) with standard small-molecule Gd chelates.^[@ref11]^ The optical imaging technique has significant advantages, such as excellent sensitivity, high resolution, contrast, instrument portability, and low cytotoxicity.^[@ref5]^ Moreover, multimodal imaging probes can provide more precise information for disease diagnosis and can be used to shuttle drugs into tumor tissue.^[@ref12]^

Most of the available reports on different rare earth (RE) orthovanadate nanomaterials have focused on the YVO~4~ and LaVO~4~ platforms.^[@ref13]−[@ref16]^ Because of the lackness of significant magnetic characteristics, the nanophosphors have been used only for biomedical applications, but they have not been used as MRI CAs.^[@ref16]^ Actually, gadolinium vanadate (GdVO~4~) is an essential host matrix, which is widely used in near-infrared (NIR) light and activated RE oxide phosphors.^[@ref17],[@ref18]^ However, concerns have recently been raised about brain deposition of the small-molecule Gd chelates currently used in clinical practice.^[@ref19],[@ref20]^ Compared with commercial small-molecule Gd chelate complexes, Gd-based inorganic nanoparticles (NPs) incorporate Gd^3+^ ions into a solid structure rather than into organic molecules, effectively avoiding the possibility of dissociation and the consequent leakage of Gd^3+^ while minimizing related toxicity and increasing the proton relaxivity.^[@ref21]^ A series of inorganic Gd-based compounds have been used for MRI contrast enhancement, including gadolinium oxides (Gd~2~O~3~),^[@ref22],[@ref23]^ gadolinium fluorides (GdF~3~, NaGdF~4~),^[@ref24]−[@ref26]^ gadolinium hydroxides (Gd(OH)~3~),^[@ref27]^ and gadolinium oxysalts (GdVO~4~, GdPO~4~).^[@ref28]−[@ref30]^ Furthermore, in multifunctional imaging fields, these NPs are promising vehicles for carrying luminescence-imaging cations, especially trivalent lanthanide ions (Ln^3+^). Notably, some of these new MRI CAs demonstrate both *T*~1~ and *T*~2~ relaxation time-shortening effects, and Gd-based NPs have a high *r*~2~/*r*~1~ ratio, with dominant *T*~2~ signal enhancement.^[@ref31]^ GdVO~4~ NPs have strong potential for multimodal MRI and luminescence imaging.

RE-based luminescent NPs, consisting of a host material which is doped with Ln ions, lack fluorescence scintillation, have excellent photostability, long lives, low cytotoxicity, and extraordinary narrow emission lines.^[@ref32]^ Gadolinium orthovanadate (GdVO~4~)-based NPs can be doped with RE ions for luminescent displays because of their equal valences and similar ionic radii. When GdVO~4~ is used as a host material, the \[VO~4~\]^3--^ groups strongly absorb UV light. In addition, trivalent europium (Eu^3+^) ion-doped materials, with excellent red luminescence resulting from the ^5^D~0~ to ^7^F~2~ (620 nm) electric dipole emission transition in the visible light range, are highly suitable photoluminescent probes because of the long photoluminescence (PL) lifetime of Eu^3+^.^[@ref33]^ However, the red emission of Eu^3+^ is primarily produced via downshifting luminescence (DSL) processes, which depend on excitation by UV radiation with short wavelengths (normally \<300 nm), which limits the applications of such materials for bioimaging.^[@ref34],[@ref35]^ Bi^3+^ (bismuth) sensitizers improve the luminescence properties by shifting the excitation peak toward longer wavelengths.^[@ref36]^ In addition, Bi^3+^ functions as an activator when incorporated into the \[VO~4~\]^3--^ host material. With the 6s^2^ electronic configuration, Bi^3+^ ions doped into REVO~4~ materials doped with Bi^3+^ ions host active electrons that are first transferred from Bi^3+^ to the V^5+^ 3d^0^ configuration and then to Eu^3+^.^[@ref37],[@ref38]^

Here, we present GdVO~4~:Eu^3+^,Bi^3+^ NPs in which europium (Eu^3+^) and bismuth (Bi^3+^) are codoped into GdVO~4~ NPs for detection with MRI and DSL bioimaging. The purpose of this study was to determine both the *in vitro* and *in vivo* bimodal imaging characteristics of this new CA.

2. Results and Discussion {#sec2}
=========================

2.1. Synthesis and Structural Data {#sec2.1}
----------------------------------

[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a--c represents transmission electron microscopy (TEM) micrographs of the GdVO~4~:Eu^3+^,Bi^3+^ NPs. The low-magnification TEM images ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a,b) displayed that the NPs exhibit an oval shape with a uniform size and are uniformly dispersed. The length of each particle is approximately 20--30 nm, and the width is approximately 10 nm. The structure of an individual NP that exhibits well-defined lattice fringes was depicted via high-magnification TEM micrograph ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c).

![(a,b) TEM micrographs of GdVO~4~:Eu^3+^,Bi^3+^ NP samples, scale bar = 20 nm. (c) High-magnification TEM micrograph of the NPs, scale bar = 5 nm. (d) EDS exhibiting the NPs elementary composition of the NPs.](ao9b00444_0001){#fig1}

The purity of the NPs was investigated using energy-dispersive spectroscopy (EDS). [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d presents an EDS spectrum of the sample. This result shows that the sample contains the elements of Gd, Bi, Eu, vanadium (V), and oxygen (O) (in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d, the elemental mapping image is shown in the small red box on the bottom-left of the inset), while the carbon (C) and copper (Cu) peaks emanate from the TEM carbon-coated copper grid. These EDS measurements demonstrate the successful incorporation of a high content of Eu^3+^ and Bi^3+^ ions into the nanocrystals.

[Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a is a graphic of the GdVO~4~ crystal structure and the coordination mode for the tetragonal structure in which the Gd^3+^ and O^2--^ ions tetrahedrally coordinate with the V^5+^ cations in the spaces among the isolated VO~4~ tetrahedral units. Therefore, Gd^3+^ ions and the surrounding eight O^2--^ ions create a distorted GdO~8~ dodecahedron. VO~4~ tetrahedra and GdO~8~ dodecahedra alternate and share edges, with Gd^3+^ and V^5+^ ions in a direct line that is parallel to the *c*-axis.^[@ref39],[@ref40]^

![(a) Schematic of the tetragonal-phase GdVO~4~ structure (coordination mode). (b) FTIR spectrum of GdVO~4~:Eu^3+^,Bi^3+^ NPs. (c) SAED pattern of GdVO~4~:Eu^3+^,Bi^3+^ NPs. (d) XRD pattern of the GdVO~4~:Eu^3+^,Bi^3+^ sample.](ao9b00444_0002){#fig2}

In [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c, the selected area electron diffraction (SAED) pattern displays a bright diffraction rosette are due to the (200), (220), and (400) crystal phases. Therefore, the NPs showed high crystallinity, forming a typical and pure tetragonal phase. In addition, in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}d, the X-ray diffraction (XRD) patterns of the GdVO~4~:Eu^3+^,Bi^3+^ consisting of peaks that follow the normal pattern of GdVO~4~ (JCPDS, card no. 72-0277), including the presence of peaks corresponding to the GdVO~4,~ which has a cubic zircon crystal structure (*I*4~1~/*amd* space group).^[@ref37]^ The NPs are pure-phase GdVO~4~ because no other peaks are observed.

A Fourier transform infrared (FTIR) spectroscopy absorption spectrum is shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b. The characteristic peak arising from the vanadium-oxygen stretching of tetrahedra appears at 800 nm; and this peak is known to appear in the region from 800 to 1050 cm^--1^.^[@ref41]^ Peaks of 3400 and 1600 cm^--1^ result from the widening absorptions of water.

2.2. Optical Properties and Spectroscopic Data {#sec2.2}
----------------------------------------------

Unfortunately, using UV excitation for *in vivo* imaging is limited by its uncaging process, which is very harmful, and it is difficult to apply this method to deep tissues because of the poor tissue penetration depth.^[@ref4],[@ref42]^ Downshifting emission excited by UV radiation (360 nm) cannot be effectively used for *in vivo* bioimaging limited by the greatly absorption of biological tissue in the UV spectral region (the quite short penetration length for the excitation radiation). In contrast, because of the advantages of NIR light, such as its tissue penetrability and low damage to cells and tissues, NIR light bands are ideal for biomedical applications.^[@ref43]^ The upconversion luminescence of Nd^3+^ can be excited and emitted at 808 nm, which is in the NIR range. It can achieve a higher signal-to-noise ratio and deeper tissue penetration when applied to small animal imaging.^[@ref44]^ Fortunately, phosphors could be excited by near-UV radiation, as the excitation peak of GdVO~4~:Eu^3+^ can be shifted toward longer wavelengths if doped with Bi^3+^.^[@ref34]^

For luminescence imaging, the emission spectra and PL excitation of GdVO~4~:Eu^3+^,Bi^3+^ were examined. GdVO~4~ is a superb host material for downconversion because of its efficient energy transfer to the excited states of RE^3+^ dopants and strong absorption in the UV range.^[@ref40]^ The 280 nm excitation band is well known as the characteristic excitation spectral peak of GdVO~4~:Eu^3+^, on account of charge-transfer band from O^2--^ to V^5+^ within \[VO~4~\]^3--^ groups; subsequently energy is transferred to the Eu^3+^ cations.^[@ref34],[@ref43]−[@ref46]^ The excitation spectra were because of the main emission line of Eu^3+^ ions in REVO~4~ at 618 nm, and they were broadly examined in the near-UV range. In [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a, the Bi^3+^ cations were introduced into the host lattice that leads to a new energy band, the maximum location of the wide absorption band, which is centered at approximately 360 nm. This shift can be explained by the appearance of the Bi^3+^ to V^5+^ CT process, following by energy transfer to Eu^3+^ cations.^[@ref47]^

![(a) PL excitation and emission spectrum (Ex = 360 nm, Em = 618 nm) of GdVO~4~:Eu^3+^,Bi^3+^ NPs. (b) Schematic diagram of the proposed energetic processes occurring in the GdVO~4~:Eu^3+^,Bi^3+^ samples. (c) Transmissivity spectrum of the samples; the inset shows the sample under near-UV-light and white-light excitation. (d) Luminescence time traces of the GdVO~4~:Eu^3+^,Bi^3+^ NPs under UV-light irradiation for 1 h.](ao9b00444_0003){#fig3}

In [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a, under UV excitation at 360 nm, emission spectra of the suspensions of the NPs displayed the characteristic transitions of Eu^3+^ cations from ^5^D~0~ to ^7^F~*J*~ (*J* = 1--4), and the ^5^D~0~ to ^7^F~2~ transition induces the highest intensity emission line at 618 nm.^[@ref33]^ The electric dipole transition ^5^D~0~ to ^7^F~2~ leads to the strong red light of GdVO~4~:Eu^3+^,Bi^3+^ NPs. In addition, the schematic diagram of energy-transfer processes of different ions shown in the emission spectrum are displayed in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b.

The transmissivity (*T*) of the GdVO~4~:Eu^3+^,Bi^3+^ NP solution is shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c, indicating that the light wavelength is broadened. Furthermore, under visible-light irradiation, the transmissivity of the material solution increased, and the *T* value approached 1. In accordance with the *T* value, the material solutions absorb near-UV light and emit red visible light (inset of [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c).

To determine the photostability of the NPs, luminescence time traces of GdVO~4~:Eu^3+^,Bi^3+^ NPs were obtained with 2 min bins under irradiation for 1 h. The result shows that no photobleaching was observed after constant irradiation, demonstrating the good photostability of the GdVO~4~:Eu^3+^,Bi^3+^ NPs for long-term bioimaging ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d).

2.3. Cell Imaging {#sec2.3}
-----------------

In [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c--e, the uptake characteristics of the prepared NPs by HepG2 cells (human liver HCC cells) were tested by confocal laser-scanning microscopy, which was recorded by the tetramethylrhodamine (TRITC) channel. In the interior of the cells, a bright red emission was observed. This suggests that the HepG2 cells can be effectively taken up by the NPs. The results indicate that the NPs are suitable CAs for fluorescence imaging *in vitro*. However, the low emission wavelength of the NPs is not suitable for in-depth *in vivo* fluorescence imaging.^[@ref48]^

![Magnetic properties of GdVO~4~:Eu^3+^,Bi^3+^ NPs: (a) RT magnetization field (*M*--*H*) curve. (b) DLS fluorescence imaging under UV light (the right photo shows the control sample under visible light). Fluorescence images of HepG2 incubated with NPs: (c) TRITC channel, (d) DAPI channel, and (e) merged channels.](ao9b00444_0004){#fig4}

2.4. Magnetic Properties and MRI Applications {#sec2.4}
---------------------------------------------

To make the GdVO~4~:Eu^3+^,Bi^3+^ NPs sufficiently compatible for further MRI applications, their magnetic properties were investigated with a vibrating sample magnetometer (VSM). As shown in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a, the room-temperature (RT) magnetization curve was linearly correlated with the magnetization intensity of 1.28 emu/g of NPs at 10 kOe, indicating that the NPs have potential applications in MRI.

[Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a,b shows *in vitroT*~1~ and *T*~2~ measurements for Gd^3+^-doped RE NPs in aqueous suspensions with different Gd^3+^ concentrations. The literature contains many reports showing that Gd^3+^-doped RE NPs have extremely low relaxivity, which limits their applications. In fact, most reports have focused on the *T*~1~ contrast effect but not the *T*~2~ contrast effect. Paramagnetic Gd-based MRI CAs exhibit increased signal intensity in the *T*~1~-weighted images, so they are defined as "positive CAs".^[@ref50]^ Actually, Gd^3+^ ions have seven unpaired electrons, which can generate large magnetic fluctuations, resulting in the shortening of the *T*~1~ and *T*~2~ values of the surrounding protons. In general, a low concentration of Gd^3+^ shortens the *T*~1~ values, whereas extreme *T*~2~ shortening occurs at high Gd^3+^ concentrations. The GdVO~4~:Eu^3+^,Bi^3+^ NPs exhibit a high signal intensity, with an *r*~1~ value of *r*~1~ = 7.87 mM^--1^ s^--1^ and an *r*~2~ value of 58.39 mM^--1^ s^--1^. The *r*~2~/*r*~1~ ratio of the NPs was calculated as 7.42, indicating that the GdVO~4~:Eu^3+^,Bi^3+^ NPs have potential applications as dual-weighted MRI CAs (both *T*~1~ and *T*~2~) for *in vivo* MRI,^[@ref49]^ although the high *r*~1~ (*r*~1~ = 7.87 mM^--1^ s^--1^) of the GdVO~4~:Eu^3+^,Bi^3+^ NPs was also observed. Obviously, the NPs' *r*~2~/*r*~1~ ratio is higher than the clinical value (*r*~2~/*r*~1~ ratio close to 1), primarily due to the *T*~2~-shortening effect. Additionally, GdVO~4~-related NPs have been mostly used as *T*~1~-weighted CAs *in vitro* and *in vivo*,^[@ref28],[@ref51]^ and few studies on the applications of these NPs for *T*~2~-weighted MRI have been conducted.

![(a,b) Curves of longitudinal and transverse vs metal concentration of GdVO~4~:Eu^3+^,Bi^3+^ NPs at 3.0 T. (c) Contrast intensities of the tumors, normal hepatic tissues compared with air. (d) *T*~2~WI of tumor-bearing nude mice *in vivo* before (left: *t* = 0 min) and after (right) the injection of GdVO~4~:Eu^3+^,Bi^3+^ NPs into the tail vein. The red circle shows the tumor site.](ao9b00444_0005){#fig5}

Therefore, for *in vivo* MRI studies, we concentrated on the function of the NPs as *T*~2~ MRI CAs. As shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}d, tumor-bearing BALB/c nude mice were intravenously injected at a dose of 10 mg of Gd per kg of mice body weight before recording by *T*~2~WI. After injecting the CA, a significant decrease of approximately 44% at 10 min (instead of an increase) was observed in the signal strength of the hepatic parenchyma regions in *T*~2~WI by measuring the signal intensities of the regions of tumor and liver regions, possibly due to the effective uptake of NPs. Meanwhile, the tumor tissue showed an enhancement of 27% in the tumor at 10 min ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}c), suggesting an obvious *T*~1~ effect of the tumor tissue. This finding is consistent with previous reports of a lack of Kupffer cells in HCCs.^[@ref52],[@ref53]^

2.5. Biocompatibility and Toxicity {#sec2.5}
----------------------------------

Before GdVO~4~:Eu^3+^,Bi^3+^ NPs can be used for *in vivo* multimodal imaging, toxicity testing is crucial. The NPs' cytotoxicity was evaluated by a Cell Counting Kit-8 (CCK-8) assay on HepG2 cells and human umbilical vein endothelial cells (HUVECs). HepG2 cells and HUVECs were incubated for 24 h in NP suspensions with NP concentrations ranging between 0 and 10 *μ*M. In [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, the change in proliferation was negligible for the treated cells.

![Viability of HepG2 cells (a) and HUVECs (b) after incubation with GdVO~4~:Eu^3+^,Bi^3+^ NPs at increasing Gd concentrations. (a,b) Cell viability was measured by a CCK-8 array using the means and SD of the number of experiments per experimental group.](ao9b00444_0006){#fig6}

To further evaluate the long-term safety of the GdVO~4~:Eu^3+^,Bi^3+^ NPs, 20 healthy BALB/c mice were sacrificed and dissected at 0, 3, 7, and 14 days after intravenous administration with GdVO~4~:Eu^3+^,Bi^3+^ NP suspension (*n* = 5, respectively). Histological analysis (in [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}) revealed that the organs (heart, spleen, liver, lung, and kidney) were normal. In addition, no deaths or behavioral changes were observed among the animals after NP administration, indicating that the GdVO~4~:Eu^3+^,Bi^3+^ NPs are biocompatible.

![H&E-stained images of different organs after intravenous administration of GdVO~4~:Eu^3+^,Bi^3+^ NPs into normal mice at 0, 3, 7, and 14 days (scale bar = 100 *μ*m).](ao9b00444_0007){#fig7}

3. Experimental Section {#sec3}
=======================

3.1. Materials {#sec3.1}
--------------

Fetal bovine serum (FBS) was purchased from Invitrogen (Carlsbad, CA). CCK-8 was acquired from Dojindo, Japan. Trypsin, phosphate-buffered saline (PBS) and RPMI 1640 medium were supplied by HyClone (Thermo, USA). Other reagents were obtained from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China). All chemicals were used as acquired without further purification. Ultrapure water was obtained from a Milli-Q water system.

3.2. NPs Synthesis {#sec3.2}
------------------

The GdVO~4~:Eu^3+^,Bi^3+^ NPs were synthesized using our group's previously established method for preparing layered RE hydroxides.^[@ref53],[@ref54]^ During GdVO~4~:Eu^3+^,Bi^3+^ NPs' synthesis, suitable amounts of the RE precursor LnCl~3~ (Ln = Gd, Eu, Bi) were dissolved in ultrapure water to a concentration of 0.5 M. Under vigorous agitation, 1 mL of PEI solution (10% by weight) was added. The resulting solution was purged with nitrogen for 1 min to eliminate oxygen after stirring for another 5 min. The mixture was sealed into a 50 mL Teflon-lined autoclave, which was maintained at 200 °C for 2.5 h. The reaction mixture was stirred magnetically to remove the supernatant via centrifugation at 10 000 rpm for 5 min, after naturally cooling to RT. The precipitate was washed twice by ethanol and once with water and then redispersed with 5.0 mL Milli-Q water. Powder was obtained after the precipitate was dried for 12 h at 40 °C.

3.3. Characterization of the NPs {#sec3.3}
--------------------------------

A transmission electron microscope (Tecnai G2 F20 S-TWIN, FEI, USA) was used to obtain the TEM micrographs of the GdVO~4~:Eu^3+^,Bi^3+^ NPs. EDS coupled with TEM was used to analyze the element compositions of the NPs. An X'Pert Pro diffractometer (X'Pert Pro MPD DY129, PANalytical, Netherlands) was used to conduct XRD. The crystal structure was determined through SAED (XRD, AXIS Ultra DLD, UK). FTIR (Nicolet 6700, Thermo Fisher Scientific, USA) was used to characterize the samples. Fluorescence emission spectra of the NPs were observed on a Hitachi F-4500 fluorescence spectrophotometer equipped with a Xe lamp excitation source. The NPs' photostability was assessed by using a Cary 5000 UV--vis--NIR spectrometer to analyze the absorption spectra of immobilized NPs under continuous UV irradiation.

3.4. Cell Culture and Cytotoxicity Test {#sec3.4}
---------------------------------------

The HepG2 cell line and HUVEC line were supplied from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). The cells were incubated at 37 °C under 5% CO~2~ atmosphere, with high-glucose Dulbecco's modified Eagle's medium (HyClone), within 1% streptomycin/penicillin (HyClone) and 10% FBS. A CCK-8 assay (Dojindo, Japan) was used to determine the *in vitro* cytotoxicity of the NPs. Briefly, 5 × 10^3^ cells of the HepG2 cells or HUVECs were planted into 96-well plates. After seeding for 24 h, the cells were then exposed to NP solutions at different concentrations and cultured overnight. The gadolinium concentrations were 0, 0.001, 0.01, 0.1, 1.0, and 10.0 *μ*M. The cells were then washed by PBS twice and tested by CCK-8 assay at 37 °C. The absorbance at 450 nm was measured using a Varioskan Flash microplate reader. Every result is reported as the average of six samples; the data are shown as the mean ± standard deviation (SD).

3.5. Cellular Uptake and Imaging {#sec3.5}
--------------------------------

HepG2 cells were used to demonstrate the suitability of GdVO~4~:Eu^3+^,Bi^3+^ NPs for bioimaging. Typically, the 2 × 10^5^ HepG2 was incubated in each well of a 6-well plate with cover glasses for 24 h. Following, 1000 *μ*g/mL NPs were added to each chamber after refreshing the growth medium. Then, cocultured for 2 h at 37 °C under a moist atmosphere of 5% CO~2~. The cells were fixed in 4% paraformaldehyde solution for 15 min at RT after washing three times in PBS and then stained with a DAPI solution. The stained cells were washed and detected via confocal laser-scanning microscope (Ni-E, Nikon, Japan) with a 20× lens to obtain the luminescence images.

3.6. Establishment of a Liver Orthotopic Transplantation Tumor-Bearing Mouse Model {#sec3.6}
----------------------------------------------------------------------------------

The animal experiment was conducted following the guidelines of the Animal Care and Use Committee of Sichuan University. Twenty male 7-week-old BALB/c nude mice, each weighed approximately 20 g, were acquired from the Institute of Experimental Animals, Sichuan Academy of Medical Sciences. HepG2 cells were harvested and resuspended in sterile PBS. For the orthotopic xenograft tumor model, mice were anesthetized via an intraperitoneal administration of chloral hydrate (10 wt %), and 1 × 10^6^ HepG2 cells in 10 *μ*L were injected slowly in the lower left lobe of the hepar (the largest one) after laparotomy directly.^[@ref55]^

3.7. MR Relaxometry and *in Vivo* Imaging {#sec3.7}
-----------------------------------------

The magnetization values of the NPs were measured by a VSM (Lake Shore 7410) at RT under an applied field ranging between 0 and 2.0 T. A 3.0 T clinical MRI instrument (Siemens Trio Tim) was performed to study *in vitro* MR relaxometry. To measure the MR relaxivity *r*~1~ and *r*~2~ values, the GdVO~4~:Eu^3+^,Bi^3+^ NP solutions of different Gd^3+^ concentrations (0.1, 0.2, 0.3, 0.4, and 0.5 mM) in 4.0 mL test tubes in the PBS buffer containing 1% agarose were prepared.

Five mice with liver tumor xenografts underwent MRI with the rat coil on a 3.0 T MRI system (Siemens Trio Tim). The relevant MR parameters are as follows: *T*~2~-weighted fast spin-echo, sequence: echo time (TE): 83 ms; repetition time (TR): 3000 ms; slice thickness: 1 mm; field of view: 60 × 60 cm^2^; matrix: 320 × 320 pixels. After the tumor models were established, the mice were anesthetized with 10 wt % chloral hydrate, and 1 mmol Gd/mL of GdVO~4~:Eu^3+^,Bi^3+^ NPs was injected intravenously via the tail at a concentration of 10 mg Gd/kg mouse. Each mouse was scanned 0, 10, 30, 48, and 60 min after injection.

To quantify the contrast enhancement, ImageJ software was used to measure the signal intensity of interest in tumors and normal hepatic tissues. The signal intensities were compared after normalization.

3.8. *In Vivo* Toxicity Studies and Histological Analysis {#sec3.8}
---------------------------------------------------------

Healthy male BALB/c mice were divided into four groups (*n* = 5 for each group) randomly, and 10 mg of Gd per kg mouse weight GdVO~4~:Eu^3+^,Bi^3+^ NP suspension was intravenously injected into the BALB/c mice through the tail vein for the three test groups (*n* = 15), and the control group (*n* = 5) was injected with 0.9 wt % NaCl.

To study the histologic changes, mice were sacrificed at 0, 3, 7, and 14 days after administration. The internal organs (liver, heart, spleen, lungs, and kidneys) were collected, fixed in 4% paraformaldehyde, and embedded in paraffin. The 5 *μ*m-thick sections were evaluated with hematoxylin and eosin (H&E).

3.9. Statistical Analysis {#sec3.9}
-------------------------

All data are expressed as the mean ± SD. Every *in vitro* experiment was conducted in triplicate. *In vitro* data of different experimental groups were compared via a one-way analysis of variance and Student's *t*-test. *In vivo* data of different experimental groups were similarly compared. Statistical analysis was performed using Prism 6.0 software with *P* \< 0.05, which indicates significant differences between experimental groups.

4. Conclusions {#sec4}
==============

In conclusion, GdVO~4~ NPs containing Eu^3+^ and Bi^3+^ ions are multimodal imaging agents that enable efficient MR *T*~2~-weighted imaging and DSL luminescence imaging. The NPs can be excited in the near-UV and visible spectra ranges, and they have an excitation peak at 360 nm caused by the introduction of Bi^3+^ ions and an emission peak at 618 nm that is characteristic of the spectral profile of Eu^3+^. Photostability experiments indicated that the NPs can provide luminescence images or enable cell monitoring *in vivo* in the long term. The relaxivity of these NPs demonstrated a 7.42 mM^--1^ s^--1^ high *r*~2~/*r*~1~ ratio for 3.0 T MRI, indicating that the NPs are suitable as a negative MRI CA. This observation conforms to the *T*~2~WI. The negative contrast enhances the tumor-to-liver contrast in HCC-bearing mice. Furthermore, the good biocompatibility and low cytotoxicity of the NPs indicate their potential for biomedical applications.
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